tm
Seeing Is Believing
tm
Seeing Is Believing
SABS is currently covered by 4 analysts with an average price target of $13. This is a potential upside of $8.14 (295.14%) from yesterday's end of day stock price of $3.29.
SAB Biotherapeutics's activity chart (see below) currently has 24 price targets and 44 ratings on display. The stock rating distribution of SABS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 1.96% with an average time for these price targets to be met of 31.91 days.
Highest price target for SABS is $16, Lowest price target is $10, average price target is $13.
Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 15-Jul-2026. First documented stock forecast 05-Nov-2021.
Currently out of the existing stock ratings of SABS, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Jun-2026
$13
$9.71 (295.14%)
$13
2 months 13 days ago
(15-Jul-2026)
0/4 (0%)
$9.38 (259.12%)
Buy Since 22-Sep-2025
$10
$6.71 (203.95%)
$10
2 months 24 days ago
(04-Jul-2026)
0/6 (0%)
$6.08 (155.10%)
Buy Since 05-Nov-2021
$16
$12.71 (386.32%)
$14
3 months 11 days ago
(17-Jun-2026)
1/11 (9.09%)
$12.14 (314.51%)
217
Buy Since 28-Aug-2024
$14
$10.71 (325.53%)
$12
1 years 2 months 7 days ago
(21-Jul-2025)
0/3 (0%)
$11.3 (418.52%)
Buy Since 09-Oct-2024
$7
$3.71 (112.77%)
$11
1 years 5 months 27 days ago
(01-Apr-2025)
0/2 (0%)
$5.77 (469.11%)
What is SABS (SAB Biotherapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SABS (SAB Biotherapeutics)?
Which analyst has the most public recommendations on SABS (SAB Biotherapeutics)?
Which analyst is the currently most bullish on SABS (SAB Biotherapeutics)?
Which analyst is the currently most reserved on SABS (SAB Biotherapeutics)?
